Algert Global LLC Makes New $487,000 Investment in Agilent Technologies, Inc. (NYSE:A)

Algert Global LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 3,279 shares of the medical research company’s stock, valued at approximately $487,000.

Several other hedge funds have also recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA boosted its position in Agilent Technologies by 5.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock worth $1,952,832,000 after acquiring an additional 809,149 shares during the last quarter. Marshall Wace LLP boosted its stake in shares of Agilent Technologies by 48.6% during the 2nd quarter. Marshall Wace LLP now owns 957,128 shares of the medical research company’s stock worth $124,073,000 after buying an additional 313,155 shares during the last quarter. Jennison Associates LLC grew its stake in Agilent Technologies by 63.3% in the third quarter. Jennison Associates LLC now owns 586,439 shares of the medical research company’s stock valued at $87,075,000 after purchasing an additional 227,431 shares in the last quarter. Impax Asset Management Group plc increased its holdings in Agilent Technologies by 8.2% during the third quarter. Impax Asset Management Group plc now owns 2,667,616 shares of the medical research company’s stock worth $396,088,000 after buying an additional 203,234 shares during the last quarter. Finally, Van ECK Associates Corp increased its stake in shares of Agilent Technologies by 6.6% during the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock worth $442,011,000 after purchasing an additional 183,716 shares during the last quarter.

Agilent Technologies Stock Down 0.1 %

A stock opened at $137.97 on Friday. The company has a quick ratio of 1.37, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. Agilent Technologies, Inc. has a 52 week low of $124.16 and a 52 week high of $155.35. The company has a market cap of $39.64 billion, a PE ratio of 31.21, a price-to-earnings-growth ratio of 4.38 and a beta of 1.07. The business has a 50-day simple moving average of $137.60 and a 200 day simple moving average of $137.27.

Agilent Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be paid a $0.248 dividend. The ex-dividend date is Tuesday, December 31st. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.72%. Agilent Technologies’s dividend payout ratio (DPR) is 21.27%.

Insiders Place Their Bets

In other news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on A. Barclays dropped their price objective on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a research note on Wednesday. JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. Citigroup lifted their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Wells Fargo & Company initiated coverage on shares of Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective on the stock. Finally, TD Cowen lifted their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $143.40.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.